Home » J&J Seeks to Cope With Cancer-Drug Shortage
J&J Seeks to Cope With Cancer-Drug Shortage
J&J applied for U.S. and European regulatory approval of a new manufacturing process that would provide a short-term fix to the supply shortage of the cancer drug Doxil.
Bullfax
Bullfax
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May